BKV Corporation ("BKV") (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters have a 30-day option to ...

County Administrator James Joerke talks about the masterplans currently under board consideration as part of the Capital ...

Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family's Banpu—closed flat in its trading debut on Thursday ...

BKV Corp. IPO’d on Sept. 26, nearly two years after the Barnett Shale’s top gas producer first filed to go public.

Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas producer BKV Inc. was up fractionally over its $18 IPO price. BioAge (BIOA) ...

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

BKV shares rose by 3.1% on their New York Stock Exchange debut on Thursday. This gives the U.S. Natural Gas Producer a market cap of $1.56 Billion.

Chris Kalnin, BKV CEO, joins 'Money Movers' to discuss the company's IPO today, what investors need to know about the state ...

(Reuters) - Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

As the company is focused on developing treatments for autoimmune diseases, it is also developing MAU868, a monoclonal ...

Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...